1st Quarter - Amendment
RARE DISEASE COMPANY COALITION for RARE DISEASE COMPANY COALITION
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
HR 4758 - Accelerating Kids Access to Care Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| YOKO ROSENBAUM | — |
Pharmacy PHA
HR 1262 - Give Kids a Chance Act of 2025 S 932 - Give Kids a Chance Act of 2025 HR 946 - ORPHAN Cures Act S 3131 - ORPHAN Cures Act Technical Correction to IRA Orphan Exception HR 1414 - Camerons Law Orphan Drug Tax Credit HR 7384 - Creating Hope Reauthorization Act of 2024 S 4583 - Creating Hope Reauthorization Act of 2024
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FRISK | — |
| YOKO ROSENBAUM | — |
Science/Technology SCI
HR 1532 - Scientific EXPERT Act of 2025 S 822 - Scientific EXPERT Act of 2025
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY FRISK | — |
| YOKO ROSENBAUM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.